Company profile Seed

Last updated:

BioCaptiva

Improving the lives of millions by unlocking the full potential of liquid biopsy

A University of Edinburgh spinout

BIOCAPTIVA is a University of Edinburgh spinout developing the BioCaptis – a revolutionary cell-free DNA (cfDNA) capture device designed to transform liquid biopsy testing and enhance cancer detection.

BIOCAPTIVA’s BioCaptis can capture up to 100x more cfDNA than a conventional blood draw, increasing the quality and quantity of cfDNA available for liquid biopsy testing. This technology, by providing higher quantities of cfDNA, increases the types and stages of cancers amenable to liquid biopsy testing thereby greatly expanding the number of patients who could benefit from this approach to cancer management.

Biocaptiva's Jeremy Wheeler

BIOCAPTIVA's CEO Jeremy Wheeler

Profile Startup

Aveni

With a wealth of financial services experience and world-leading natural language processing (NLP) expertise, University of Edinburgh startup Aveni is creating cutting-edge AI solutions that are built specifically for the financial services industry.

Read
AI and Data Finance and Fintech